Inspire Medical Systems (INSP) Revenue (2017 - 2026)

Inspire Medical Systems (INSP) has 10 years of Revenue data on file, last reported at $204.6 million in Q1 2026.

• For the quarter ending Q1 2026, Revenue rose 1.62% year-over-year to $204.6 million; the trailing twelve-month figure through Mar 2026 stood at $915.2 million (up 8.94% YoY), and the FY2025 full-year result was $912.0 million, up 13.6% from the prior year.
• Revenue slipped to $204.6 million in Q1 2026, from $269.1 million in the prior quarter.
• In the past five years, Revenue ranged from a high of $269.1 million in Q4 2025 to a low of $69.4 million in Q1 2022.
• A 5-year average of $173.6 million and a median of $192.5 million in 2023 frame the typical range for Revenue.
• Across the five-year window, Revenue jumped 84.34% in 2023 and increased 1.62% in 2026, its largest moves.
• Tracing INSP's Revenue over 5 years: stood at $137.9 million in 2022, then soared by 39.6% to $192.5 million in 2023, then climbed by 24.52% to $239.7 million in 2024, then gained by 12.25% to $269.1 million in 2025, then declined by 23.97% to $204.6 million in 2026.
• Business Quant data shows INSP's Revenue at $204.6 million in Q1 2026, $269.1 million in Q4 2025, and $224.5 million in Q3 2025.